High Syntax (synergy between percutaneous coronary intervention with taxus and cardiac surgery) scores predict no-reflow in patients with st-elevation myocardial infarction

被引：0
|
作者：
Ferrante, G. [1 ]
Corrada, E. [1 ]
Zavalloni, D. [1 ]
Pagnotta, P. [1 ]
Mennuni, M. [1 ]
Rossi, M. L. [1 ]
Gasparini, G. L. [1 ]
Belli, G. [1 ]
Presbitero, P. [1 ]
机构：
[1] Clin Inst Humanitas IRCCS, Milan, Italy
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [21] Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction
    Niccoli, Giampaolo
    Andreotti, Felicita
    Marzo, Francesca
    Cecchetti, Silvia
    Santucci, Eleonora
    D'Amario, Domenico
    Pafundi, Teodosio
    Cosentino, Nicola
    Crea, Filippo
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (11) : 1210 - 1219
  • [22] Impact of clopidogrel resistance on ST-segment resolution and no-reflow in acute myocardial infarction with ST-elevation patients treated with a primary percutaneous coronary intervention
    Bozbeyoglu, Emrah
    Satilmis, Seckin
    Aksu, Huseyin
    Yildirimturk, Ozlem
    Nurkalem, Zekeriya
    CORONARY ARTERY DISEASE, 2012, 23 (08) : 523 - 527
  • [23] Relationship between no-reflow phenomenon and serotonin levels in patients with acute ST-elevation myocardial infarction who underwent primary percutaneous intervention
    Topsakal, Ramazan
    Kaya, Mehmet G.
    Karakaya, Ekrem
    Gunebakmaz, Ozgur
    Dogan, Ali
    Inanc, M. Tugrul
    Sarli, Bahadir
    Ozdogru, Ibrahim
    Ergin, Ali
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 (03): : 253 - 259
  • [24] Predictor of persistent slow/no-reflow after percutaneous coronary intervention with thrombus aspiration and distal protection for ST-elevation myocardial infarction
    Hyodo, Y.
    Kadota, K.
    Otsuru, S.
    Hasegawa, D.
    Habara, S.
    Tada, T.
    Tanaka, H.
    Fuku, Y.
    Goto, T.
    Mitsudo, K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 488 - 488
  • [25] Feasibility of lymphocyte-to-monocyte ratio in predicting no-reflow phenomenon in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
    郑宝娟
    马墩亮
    卓胜青
    田相亭
    SouthChinaJournalofCardiology, 2019, 20 (04) : 228 - 235
  • [26] THE PREDICTIVE VALUE OF R-WAVE PEAK TIME ON NO-REFLOW IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION TREATED WITH A PRIMARY PERCUTANEOUS CORONARY INTERVENTION
    Bendary, A.
    El-Husseiny, M.
    Azm, Aboul M.
    Monem, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 33 : E1 - E2
  • [27] Primary percutaneous coronary intervention in ST-elevation myocardial infarction patients following cardiac arrest
    Henry, Timothy D.
    Duval, Sue
    Mooney, Michael R.
    Menssen, Katie M.
    Kapsner, Christopher E.
    Page, David I.
    Parham, William
    Unger, Barbara T.
    Burke, M. Nicholas
    Chavez, Ivan J.
    Traverse, Jay H.
    Larson, David M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 210L - 210L
  • [28] The predictive value of R-wave peak time on no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention
    Bendary, Ahmed
    El-Husseiny, Mohamed
    Azm, Tarek Aboul
    Moneim, Ahmed Abdoul
    EGYPTIAN HEART JOURNAL, 2018, 70 (04): : 415 - 419
  • [29] Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction
    Kurtul, Alparslan
    Yarlioglues, Mikail
    Celik, Ibrahim Etem
    Duran, Mustafa
    Elcik, Deniz
    Kilic, Alparslan
    Oksuz, Fatih
    Murat, Sani Namik
    CORONARY ARTERY DISEASE, 2015, 26 (08) : 706 - 712
  • [30] Predicting the no-reflow phenomenon in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a systematic review of clinical prediction models
    Ebrahimi, Reza
    Rahmani, Mahdi
    Fallahtafti, Parisa
    Ghaseminejad-Raeini, Amirhossein
    Azarboo, Alireza
    Jalali, Arash
    Mehrani, Mehdi
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2024, 18
12345